Apparently, that came in the form of a huge government-mediated discount on the blockbuster weight loss drugs known as GLP-1s, like Wegovy and Zepbound
The Core Issue: Failure to Warn Patients of Severe Risks The central argument in the GLP-1 lawsuits is that manufacturers like Novo Nordisk and Eli Lilly knew, or should have known, about the risk of severe side effects like stomach paralysis and bowel obstruction but failed to adequately warn doctors and patients
The most common side effects are gastrointestinal, including nausea, diarrhoea, vomiting, constipation, and abdominal discomfort, occurring in approximately 2040% of patients
Our Testers Thoughts on Jocko Creatine Petes first impression of Jocko Creatine was the observation that its a black bag with individual creatine packets inside, making it incredibly travel-friendly. This earned it a rating of 5 out of 5 for packaging and convenience
In Kentucky, semaglutide can be prescribed by professionals with the titles MD
Key Companies Innovating in GLP-1 Obesity Treatments In 2025, the landscape of obesity treatment is being reshaped by innovative companies developing GLP-1 (glucagon-like peptide-1) receptor agonists